EVENTS:   The Roaring 2020s or a Rerun of the 1970s? - Edward Yardeni/Yardeni Research - 24 Mar 26   Best Equity Short Ideas Conference Call 13 - Thomas Chanos/Badger Consultants & Dr. Aaron Fletcher/Bios Research & Jonathan Telgener/Channel Dynamics & Ed Steele/Iron Blue Financials & John Zolidis/Quo Vadis Capital & Mark Hiley/The Analyst - 26 Mar 26     ROADSHOWS: Chinese Equity Ideas & Channel Checks Across 50 sub-sectors - Don Ma /Horizon Insights   •   London   23 - 27 Mar 26       Long Short European Equity Research - Harry Grist /The Analyst   •   New York   26 Mar 26       Fundamental US Healthcare Short Ideas - Dr Elliot Favus /Favus Institutional Research   •   London   27 - 27 Mar 26      
Filters

Fortnightly Publication Highlighting Latest Insights From IRF Providers

Company Research

Gland Pharma (GLAND IN) India

Healthcare

Smart Insider

M N Ravi Chandra (VP of Operations since 2004) sold 5,000 shares at INR 1,730, cutting his stake by 50%. This is only his second sale, and whilst smaller in size than his prior timely sale of 7,000 shares in Aug 21 at INR 4,035, it is concerning to see him selling at less than half the price. K V G K Raju (CTO since 2021) sold 7,992 shares at INR 1,790, reducing his holding to zero. There is no news that he is leaving. Moreover, P Balaji (Head of Logistics) sold 1,000 shares at INR 1,764, cutting his holdings in half at the lowest price he has sold shares. This is a concerning cluster of sales from key officers and all have good overall records as sellers.

Edition: 182

- 22 March, 2024